Abeona Therapeutics (ABEO) granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On July 30, 2025, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to 14 individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 34,679 restricted shares of Abeona common stock. One-third of the shares subject to such restricted stock awards will vest yearly on each anniversary of the Grant Date, such that the shares subject to such restricted stock awards granted to each employee will be fully vested on the third anniversary of the Grant Date, in each case, subject to each employee’s continued employment with Abeona on the applicable vesting dates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEO:
- AscellaHealth highlights value of HUB partnership with Abeona Therapeutics
- Abeona Therapeutics Amends Loan Agreement with Avenue
- Abeona Therapeutics’ Gene Therapy Trial for MPS IIIA: A Promising Update
- Abeona announces ZEVASKYN available at new Qualified Treatment Center
- Positive Outlook for Abeona Therapeutics Amid FDA Challenges and Promising ZEVASKYN Launch